NYSE · Key Statistics

ADC Therapeutics SA (ADCT) Key Statistics

$1.44 NYSE: ADCT Market Cap $183.84M

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for ADC Therapeutics SA (ADCT), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	-2.26
P/B ratioShare price divided by book value per share.	-1.02
P/S ratioMarket value divided by annual revenue.	2.43
PEG ratioP/E divided by the earnings growth rate.	-0.02
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.	-4.45
EV / RevenueEnterprise value against annual revenue.	4.95
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.	-46.73%
Free cash flow yieldFree cash flow as a percentage of market value.	-53.43%

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	88.75%
Operating marginRevenue left after operating costs.	-125.83%
Net marginRevenue left after every cost, including tax and interest.	-123.03%
Return on equityProfit as a percentage of shareholders’ equity.	44.63%
Return on assetsProfit as a percentage of total assets.	-34.69%
Return on capital employedOperating profit against the capital the business uses.	-51.34%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	3.03
Quick ratioThe same, excluding inventory.	2.97
Cash ratioCash alone against current liabilities.	3.73
Debt to equityTotal borrowings against shareholders’ equity.	-1.83
Debt to assetsTotal borrowings against total assets.	1.36
Interest coverageHow many times operating profit covers the interest bill.	-1.90

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$-1.12
Book value per shareShareholders’ equity divided by shares outstanding.	$0.00
Shares outstandingShares currently issued.	0
Market capitalisationShare price times shares outstanding.	$183.84M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.	$389.50M
EmployeesReported headcount.	263

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	0.00%

ADC Therapeutics SA (ADCT) statistics — frequently asked questions

What is ADC Therapeutics SA's P/E ratio?

ADC Therapeutics SA (ADCT) trades on a price-to-earnings ratio of -2.26. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is ADC Therapeutics SA's return on equity?

ADC Therapeutics SA (ADCT) reports a return on equity of 44.63%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does ADC Therapeutics SA carry?

ADC Therapeutics SA (ADCT) has a debt-to-equity ratio of -1.83, which compares total borrowings with shareholders' equity.

What is ADC Therapeutics SA's profit margin?

ADC Therapeutics SA (ADCT) keeps -123.03% of revenue as net profit after every cost, including tax and interest.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks NYSE High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.